A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2009
12/01/2009	CA2492196C Sulfotransferase inhibitors
12/01/2009	CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009	CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
11/2009
11/26/2009	WO2009143457A2 Vaccine composition containing synthetic adjuvant
11/26/2009	WO2009143280A2 Nanolipoprotein particles and related compositions, methods and systems
11/26/2009	WO2009142772A2 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
11/26/2009	WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009	WO2009142320A1 Preventative and/or therapeutic agent against atopic dermatitis
11/26/2009	WO2009142195A1 Agent for induction/maintenance of remission
11/26/2009	WO2009142186A1 Cytotoxic composition
11/26/2009	WO2009141434A1 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
11/26/2009	WO2009141142A1 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/26/2009	WO2009140984A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid
11/26/2009	WO2009140928A1 Dihydroindolinone derivatives
11/26/2009	WO2009140833A1 Collagen peptide having immunoenchancing activity from cyanea nozakii and preparation method and uses thereof
11/26/2009	WO2009140755A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	WO2009113810A3 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases
11/26/2009	WO2009056833A3 Composition
11/26/2009	WO2009043458A3 Use of oxytocin to treat many diseases
11/26/2009	WO2009043457A3 Use of human hemokinin-1 and optionally oxytocin to treat diseases involving excessive angiogenesis
11/26/2009	WO2009040024A3 Use of bim-23127 and optionally urodilatin as therapeutic agents eg for the treatment of m. tuberculosis infections
11/26/2009	WO2009039981A3 Use of (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009	WO2009039980A3 Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009	WO2009033820A3 Use of saralasin and carbetocin in combination to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009	WO2009033783A3 Use of carbetocin to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009	WO2009033782A3 Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
11/26/2009	US20090292113 Recombinant soluble Fc receptors
11/26/2009	US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009	US20090291978 Enzyme Inhibitors
11/26/2009	US20090291934 Method for decomposing an allergen
11/26/2009	US20090291917 Boron-Containing Small Molecules as Anti-Inflammatory Agents
11/26/2009	US20090291916 Trihydroxy Polyunsaturated Eicosanoid
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291877 Treatments using citrulline
11/26/2009	US20090291143 Combination of Azelastine and Steroids
11/26/2009	US20090291103 Quality control methods for oil-in-water emulsions containing squalene
11/26/2009	US20090291099 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
11/26/2009	US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof
11/26/2009	US20090291094 Antibodies and processes for preparing the same
11/26/2009	US20090291084 Anti- il-6 antibodies, compositions, methods and uses
11/26/2009	US20090291081 Dual-specific IL-1A/IL-1b antibodies
11/26/2009	US20090291080 Levels of april in serum and use in diagnostic methods
11/26/2009	US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009	US20090291077 Antagonists of IL-6 to prevent or treat Cachexia, weakness, fatigue, and/or fever
11/26/2009	US20090291050 Particulate materials
11/26/2009	US20090291020 Soft contact lens solution containing hyaluronic acid
11/26/2009	CA2826508A1 Nanoemulsion vaccines
11/26/2009	CA2725329A1 Nanoemulsion vaccines
11/26/2009	CA2725198A1 Novel soluble cd83 polypeptides, formulations and methods of use
11/26/2009	CA2725001A1 Dihydroindolone derivatives
11/26/2009	CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	CA2724592A1 Agent for maintenance of induced remission
11/26/2009	CA2724570A1 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/26/2009	CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology
11/25/2009	EP2123752A2 Novel nucleic acid
11/25/2009	EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009	EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009	EP2123663A1 Method for production of sugar oxazoline derivative
11/25/2009	EP2123662A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
11/25/2009	EP2123654A1 Pyrazolopyrimidine compound
11/25/2009	EP2123651A1 Condensed pyridine compound
11/25/2009	EP2123649A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
11/25/2009	EP2123302A1 Chronic rejection inhibitor
11/25/2009	EP2123298A1 Agent for suppressing rejection in organ transplantation comprising anti-hmgb-1 antibody
11/25/2009	EP2123291A1 IgA PRODUCTION PROMOTER
11/25/2009	EP2123282A2 Immunemodulating oligosaccharides
11/25/2009	EP2123280A1 Agent for prevention and/or treatment of systemic lupus erythematosus
11/25/2009	EP2123269A1 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/25/2009	EP2121762A1 BINDING MEMBERS FOR IgE MOLECULES
11/25/2009	EP2121760A2 Antibodies to cd200r
11/25/2009	EP2121736A1 New anti-malaria vaccine compositions and uses thereof
11/25/2009	EP2121727A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
11/25/2009	EP2121012A2 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
11/25/2009	EP2120986A2 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
11/25/2009	EP2120919A1 New combination for use in the treatment of inflammatory disorders
11/25/2009	EP2120916A1 Modulators of antigen-dependent t cell proliferation
11/25/2009	EP2120909A2 Treatments of therapy-resistant diseases comprising drug combinations
11/25/2009	EP1558595B1 Piperazinyl and diazapanyl benzamides and benzthioamides
11/25/2009	EP1325033B1 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	CN101589063A Humanized anti-factor D antibodies and uses thereof
11/25/2009	CN101589061A Antibody molecules which bind IL-17A and IL-17F
11/25/2009	CN101589047A Cathepsin proteases inhibitors
11/25/2009	CN101588815A Novel prostate kallikrein allergen
11/25/2009	CN101586115A Gene coexpression recombinant plasmid and DNA vaccine prepared from same
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585823A New immunosuppressive agent extracted from Honghuoma and extraction method and use thereof
11/25/2009	CN101585805A Preparation method of an antiallergic agent fexofenadine hydrochloride
11/25/2009	CN101585804A Synthetic method of a fexofenadine hydrochloride
11/25/2009	CN101585792A Preparation method of a piglet intestinal canal barrier function controlling substance -N-acetylcysteine
11/25/2009	CN101585506A Prescription of acanthopanax health preserving pillow and child cloth toy filling material
11/25/2009	CN101584858A Stable protein formulations
11/25/2009	CN101584809A Medicine for treating cold grasserie and method of preparing the medicine
11/25/2009	CN101584803A Medicament for improving immunizing power and preparing method thereof
11/25/2009	CN101584776A Cordyceps P.E. nutrition capsule
11/25/2009	CN101584773A Chinese herbal medicament for treating skin diseases

1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 1172